The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer’s disease — despite an FDA advisory committee concluding last year that there is not enough evidence to support the effectiveness of the treatment.
Must-Have Lifestyle Items in 2024
As we embrace 2024, staying ahead of the curve in lifestyle trends is key to enhancing our day-to-day living. From tech gadgets to home essentials,
